Pharmather Holdings Stock Price Prediction

PHRRF Stock  USD 0.16  0.01  5.88%   
The value of RSI of Pharmather Holdings' otc stock price is roughly 60 indicating that the otc stock is rather overbought by investors as of 16th of December 2024. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Pharmather, making its price go up or down.

Oversold Vs Overbought

60

 
Oversold
 
Overbought
Pharmather Holdings stock price prediction is an act of determining the future value of Pharmather Holdings shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pharmather Holdings' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pharmather Holdings and does not consider all of the tangible or intangible factors available from Pharmather Holdings' fundamental data. We analyze noise-free headlines and recent hype associated with Pharmather Holdings, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pharmather Holdings based on different types of headlines from major news networks to social media. Using Pharmather Holdings hype-based prediction, you can estimate the value of Pharmather Holdings from the perspective of Pharmather Holdings response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Pharmather Holdings. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pharmather Holdings to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Pharmather because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pharmather Holdings after-hype prediction price

    
  USD 0.16  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Pharmather Holdings Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.010.146.62
Details

Pharmather Holdings After-Hype Price Prediction Density Analysis

As far as predicting the price of Pharmather Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharmather Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Pharmather Holdings, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Pharmather Holdings Estimiated After-Hype Price Volatility

In the context of predicting Pharmather Holdings' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharmather Holdings' historical news coverage. Pharmather Holdings' after-hype downside and upside margins for the prediction period are 0.01 and 6.64, respectively. We have considered Pharmather Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.16
0.16
After-hype Price
6.64
Upside
Pharmather Holdings is out of control at this time. Analysis and calculation of next after-hype price of Pharmather Holdings is based on 3 months time horizon.

Pharmather Holdings OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Pharmather Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharmather Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharmather Holdings, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.06 
6.53
 0.00  
 0.00  
0 Events / Month
8 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.16
0.16
0.00 
0.00  
Notes

Pharmather Holdings Hype Timeline

Pharmather Holdings is at this time traded for 0.16. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pharmather is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.06%. %. The volatility of related hype on Pharmather Holdings is about 46934.38%, with the expected price after the next announcement by competition of 0.16. About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharmather Holdings recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be within a week.
Check out Pharmather Holdings Basic Forecasting Models to cross-verify your projections.

Pharmather Holdings Related Hype Analysis

Having access to credible news sources related to Pharmather Holdings' direct competition is more important than ever and may enhance your ability to predict Pharmather Holdings' future price movements. Getting to know how Pharmather Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharmather Holdings may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ADILAdial Pharmaceuticals 0.01 6 per month 2.95 (0.01) 7.21 (5.83) 22.17 
RNAZTranscode Therapeutics(1.09)7 per month 7.91  0.03  23.35 (12.12) 74.31 
ADTXAditxt Inc(0.03)8 per month 0.00 (0.53) 6.06 (28.15) 42.69 
RVPHReviva Pharmaceuticals Holdings(0.04)6 per month 4.95  0.18  15.38 (8.06) 40.06 
ATXIAvenue Therapeutics 0.20 4 per month 0.00 (0.16) 6.03 (6.67) 24.31 
PMBHFPharmala Biotech Holdings 0.00 0 per month 6.16  0.01  4.17 (17.39) 108.92 
TRYPFTryp Therapeutics 0.00 0 per month 10.40  0.07  22.17 (21.87) 75.11 
PSYBFPsyBio Therapeutics Corp 0.00 0 per month 0.00  0.12  0.00  0.00  20,998 
AWKNFAwakn Life Sciences 0.00 0 per month 0.00 (0.01) 18.00 (19.73) 43.08 
XOMAOXOMA Corporation 0.00 0 per month 0.06 (0.14) 0.51 (0.39) 2.44 
FBIOFortress Biotech(0.06)9 per month 4.51  0.02  9.52 (5.78) 26.13 
CKPTCheckpoint Therapeutics 0.30 4 per month 3.66  0.19  7.91 (5.73) 19.17 
ZIVOZivo Bioscience 0.04 4 per month 0.00 (0.16) 5.31 (6.67) 36.36 
LUMOLumos Pharma(0.07)5 per month 2.38  0.08  5.95 (5.19) 16.25 
WSNAFWesana Health Holdings 0.00 0 per month 24.79  0.18  101.82 (50.44) 207.28 
BVAXFBiovaxys Technology Corp 0.00 0 per month 5.56  0  11.78 (8.24) 37.09 
GHRSGH Research PLC 0.42 6 per month 0.00 (0.03) 8.59 (5.76) 26.09 
AGNPFAlgernon Pharmaceuticals 0.00 0 per month 0.00 (0.04) 16.58 (15.66) 55.53 
AXIMAxim Biotechnologies 0.00 0 per month 13.94  0.02  50.00 (33.33) 133.33 
RGBPRegen BioPharma 0.00 0 per month 22.71  0.15  100.00 (47.83) 196.39 
RGBPPRegen BioPharma 0.00 0 per month 24.67  0.14  85.45 (46.47) 336.94 
MYMXMymetics Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PKTXProtokinetix 0.00 0 per month 10.53  0.01  25.00 (21.15) 64.26 

Pharmather Holdings Additional Predictive Modules

Most predictive techniques to examine Pharmather price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmather using various technical indicators. When you analyze Pharmather charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pharmather Holdings Predictive Indicators

The successful prediction of Pharmather Holdings stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharmather Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharmather Holdings based on analysis of Pharmather Holdings hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharmather Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharmather Holdings's related companies.

Story Coverage note for Pharmather Holdings

The number of cover stories for Pharmather Holdings depends on current market conditions and Pharmather Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharmather Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharmather Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Pharmather Holdings Short Properties

Pharmather Holdings' future price predictability will typically decrease when Pharmather Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharmather Holdings often depends not only on the future outlook of the potential Pharmather Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharmather Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding88.2 M

Complementary Tools for Pharmather OTC Stock analysis

When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets